Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase.
It is generally recognised that novel antiviral drugs, less prone to resistance, would be a desirable alternative to current drug options in order to be able to treat potentially serious influenza infections. The viral polymerase, which performs transcription and replication of the RNA genome, is an...
Main Authors: | Eva Kowalinski, Chloe Zubieta, Andrea Wolkerstorfer, Oliver H J Szolar, Rob W H Ruigrok, Stephen Cusack |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Pathogens |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22876177/?tool=EBI |
Similar Items
-
Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.
by: Juan Reguera, et al.
Published: (2010-09-01) -
Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase
by: Ao Hu, et al.
Published: (2020-02-01) -
Nucleoproteins of Negative Strand RNA Viruses; RNA Binding, Oligomerisation and Binding to Polymerase Co-Factor
by: Thibaut Crépin, et al.
Published: (2010-01-01) -
Host determinant residue lysine 627 lies on the surface of a discrete, folded domain of influenza virus polymerase PB2 subunit.
by: Franck Tarendeau, et al.
Published: (2008-01-01) -
Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.
by: Weimei Xing, et al.
Published: (2017-01-01)